STOCK TITAN

Inmed Pharmaceuticals Inc (INM) Revenue by Year

INM

Inmed Pharmaceuticals Inc generated $4.9M in revenue in fiscal year 2025. This represents an increase of 7.5% from the prior fiscal year. The table below carries 6 fiscal years, from 2020 to 2025, and the quarters Inmed Pharmaceuticals Inc has filed alongside them.

FY2025 annual
Revenue $4.9M
YoY +7.5%
Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended Mar 31, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

INM Revenue by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY25S-4FY24S-4FY2310-KFY2210-KFY2110-KFY2010-K
Revenue$4.9M+7.5%$4.6M+11.2%$4.1M+279.6%$1.1M-42.8%$1.9MN/A

INM Revenue by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ3'26S-4Q2'2610-QQ1'2610-QQ4'25S-4Q3'2510-QQ2'2510-QQ1'2510-QQ4'24S-4Q3'2410-QQ2'2410-QQ1'2410-QQ4'2310-K
RevenueN/A$820K-26.2%$1.1M-11.4%$1.3M+1.7%$1.3M+7.6%$1.1M-10.4%$1.3M+40.2%$1.3M-44.5%$1.2M+13.4%$1.2M+164.0%$902K+181.1%$2.3M

What revenue means

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.

More Inmed Pharmaceuticals Inc financials

Frequently Asked Questions

What was Inmed Pharmaceuticals Inc's revenue in fiscal year 2025?

Inmed Pharmaceuticals Inc generated $4.9M in revenue in fiscal year 2025.

How fast is Inmed Pharmaceuticals Inc's revenue growing?

Inmed Pharmaceuticals Inc (INM) revenue rose by 7.5% year over year, from $4.6M to $4.9M in fiscal year 2025.

What does revenue mean on a financial statement?

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what Inmed Pharmaceuticals Inc (INM) reported on that line in every period on record.